Ocean Biomedical, Inc.

Ocean Biomedical, Inc. trades under the ticker AEHA following its business combination with Aesther Healthcare Acquisition Corp., a blank-check company sponsored by Aesther Healthcare Sponsor LLC that completed its IPO in 2021 targeting the healthcare sector. The February 2023 Form 8-K filing marks a key post-merger disclosure milestone for the combined entity, which operates as a biopharmaceutical company with a pipeline rooted in research from Brown University, focused on oncology and infectious disease. The company is currently publicly traded following the de-SPAC transaction, placing it in the life sciences and biopharma segment of the SPAC market. Visit SpacDesk and sign up for full data, filings history, and deal analytics on AEHA and hundreds of other SPAC transactions.